Your browser doesn't support javascript.
loading
Orexins and fear: implications for the treatment of anxiety disorders.
Flores, África; Saravia, Rocío; Maldonado, Rafael; Berrendero, Fernando.
Afiliação
  • Flores Á; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Saravia R; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Maldonado R; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain. Electronic address: rafael.maldonado@upf.edu.
  • Berrendero F; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, PRBB, C/Doctor Aiguader 88, 08003 Barcelona, Spain. Electronic address: fernando.berrendero@upf.edu.
Trends Neurosci ; 38(9): 550-9, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26216377
ABSTRACT
An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system. Although this system was initially believed to be primarily involved in the regulation of feeding behavior, recent studies have shown that orexins also modulate neural circuits implicated in the expression and extinction of fear memories. Here, we discuss recent findings involving orexins in anxiety disorders and current clinical trials using orexin ligands that could be applied to identify new therapies for diseases characterized by pathological fear.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Medo / Orexinas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Trends Neurosci Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Ansiedade / Medo / Orexinas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Trends Neurosci Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha